{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:18:57Z","timestamp":1792451937414,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cannabinoid 1 receptor (CB1R) expression is upregulated in the liver with viral hepatitis, cirrhosis, and both alcoholic and non-alcoholic fatty liver disease (FLD), whereas its expression is muted under usual physiological conditions. Inhibiting CB1R has been shown to be beneficial in preserving hepatic function in FLD but it is unclear if inhibiting CB1R during an inflammatory response to an acute hepatic injury, such as toxin-induced injury, would also be beneficial. We found that intrinsic CB1R in hepatocytes regulated liver inflammation-related gene transcription. We tested if nullification of hepatocyte-specific CB1R (hCNR1<jats:sup>\u2212\/\u2212<\/jats:sup>) in mice protects against concanavalin A (Con A)-induced liver injury. We looked for evidence of liver damage and markers of inflammation in response to Con A by measuring liver enzyme levels and proinflammatory cytokines (e.g., TNF-\u03b1, IL-1\u03b2, IL-6, IL-17) in serum collected from hCNR1<jats:sup>\u2212\/\u2212<\/jats:sup> and control mice. We observed a shift to the right in the dose-response curve for liver injury and inflammation in hCNR1<jats:sup>\u2212\/\u2212<\/jats:sup> mice. We also found less inflammatory cell infiltration and focal necrosis in livers of hCNR1<jats:sup>\u2212\/\u2212<\/jats:sup> mice compared to controls, resulting from downregulated apoptotic markers. This anti-apoptotic mechanism results from increased activation of nuclear factor kappa B (NF-\u03baB), especially cAMP-dependent cannabinoid signaling and membrane-bound TNF-\u03b1, via downregulated TNF-\u03b1 receptor 2 (TNFR2) transcription levels. Collectively, these findings provide insight into involvement of CB1R in the pathogenesis of acute liver injury.<\/jats:p>","DOI":"10.1038\/s41419-020-03261-8","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T11:39:11Z","timestamp":1607513951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-\u03baB signaling"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-1319","authenticated-orcid":false,"given":"Yoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanikkai Raja","family":"Aseer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaekwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabha","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Henrique","family":"Mazucanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paritosh","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ire E.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Lehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8477-6452","authenticated-orcid":false,"given":"Qing-Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine M.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"3261_CR1","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","volume":"382","author":"MA Heneghan","year":"2013","unstructured":"Heneghan, M. A., Yeoman, A. D., Verma, S., Smith, A. D. & Longhi, M. S. Autoimmune hepatitis. Lancet 382, 1433\u20131444 (2013).","journal-title":"Lancet"},{"key":"3261_CR2","doi-asserted-by":"crossref","unstructured":"Ballegeer, M. & Libert, C. Different cell types involved in mediating concanavalin A induced liver injury: a comprehensive overview. J. Gastroenterol. Hepatol. Res. 1 (2016).","DOI":"10.24966\/GHR-2566\/100001"},{"key":"3261_CR3","first-page":"190","volume":"21","author":"F Gantner","year":"1995","unstructured":"Gantner, F., Leist, M., Lohse, A. W., Germann, P. G. & Tiegs, G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21, 190\u2013198 (1995).","journal-title":"Hepatology"},{"key":"3261_CR4","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1073\/pnas.040566697","volume":"97","author":"K Takeda","year":"2000","unstructured":"Takeda, K. et al. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl Acad. Sci. USA 97, 5498\u20135503 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3261_CR5","doi-asserted-by":"publisher","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","volume":"22","author":"R G\u00f3mez","year":"2002","unstructured":"G\u00f3mez, R. et al. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J. Neurosci. 22, 9612\u20139617 (2002).","journal-title":"J. Neurosci."},{"key":"3261_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/sj.bjp.0707511","volume":"153","author":"S Lotersztajn","year":"2008","unstructured":"Lotersztajn, S. et al. CB2 receptors as new therapeutic targets for liver diseases. Br. J. Pharmacol. 153, 286\u2013289 (2008).","journal-title":"Br. J. Pharmacol."},{"key":"3261_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nm1421","volume":"12","author":"F Teixeira-Clerc","year":"2006","unstructured":"Teixeira-Clerc, F. et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat. Med. 12, 671 (2006).","journal-title":"Nat. Med."},{"key":"3261_CR8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jhep.2013.03.032","volume":"59","author":"A Mallat","year":"2013","unstructured":"Mallat, A., Teixeira-Clerc, F. & Lotersztajn, S. Cannabinoid signaling and liver therapeutics. J. Hepatol. 59, 891\u2013896 (2013).","journal-title":"J. Hepatol."},{"key":"3261_CR9","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","volume":"128","author":"B Julien","year":"2005","unstructured":"Julien, B. et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128, 742\u2013755 (2005).","journal-title":"Gastroenterology"},{"key":"3261_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/apt.12673","volume":"39","author":"P Basu","year":"2014","unstructured":"Basu, P., Aloysius, M., Shah, N. & Brown, R. Jr The endocannabinoid system in liver disease, a potential therapeutic target. Aliment. Pharmacol. Ther. 39, 790\u2013801 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"3261_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1478-3231.2011.02496.x","volume":"31","author":"J Trebicka","year":"2011","unstructured":"Trebicka, J. et al. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Liver Int. 31, 860\u2013870 (2011).","journal-title":"Liver Int."},{"key":"3261_CR12","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1172\/JCI34827","volume":"118","author":"D Osei-Hyiaman","year":"2008","unstructured":"Osei-Hyiaman, D. et al. Hepatic CB 1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J. Clin. Invest. 118, 3160\u20133169 (2008).","journal-title":"J. Clin. Invest."},{"key":"3261_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep33302","volume":"6","author":"I Gonz\u00e1lez-Mariscal","year":"2016","unstructured":"Gonz\u00e1lez-Mariscal, I. et al. Human CB1 receptor isoforms, present in hepatocytes and \u03b2-cells, are involved in regulating metabolism. Sci. Rep. 6, 33302 (2016).","journal-title":"Sci. Rep."},{"key":"3261_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1872-034X.2008.00473.x","volume":"39","author":"M Kojima","year":"2009","unstructured":"Kojima, M. et al. Selective CB1 cannabinoid receptor antagonist, SR141716A, attenuates liver injury induced by concanavalin A. Hepatol. Res. 39, 408\u2013414 (2009).","journal-title":"Hepatol. Res."},{"key":"3261_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1124\/mol.108.047035","volume":"74","author":"VL Hegde","year":"2008","unstructured":"Hegde, V. L. et al. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol. Pharmacol. 74, 20\u201333 (2008).","journal-title":"Mol. Pharmacol."},{"key":"3261_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1126\/science.274.5288.782","volume":"274","author":"AA Beg","year":"1996","unstructured":"Beg, A. A. & Baltimore, D. An essential role for NF-\u03baB in preventing TNF-\u03b1-induced cell death. Science 274, 782\u2013784 (1996).","journal-title":"Science"},{"key":"3261_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/376167a0","volume":"376","author":"AA Beg","year":"1995","unstructured":"Beg, A. A., William, C. S., Bronson, R. T., Ghosh, S. & Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-\u03baB. Nature 376, 167 (1995).","journal-title":"Nature"},{"key":"3261_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells5010012","volume":"5","author":"F Christian","year":"2016","unstructured":"Christian, F., Smith, E. & Carmody, R. The regulation of NF-\u03baB subunits by phosphorylation. Cells 5, 12 (2016).","journal-title":"Cells"},{"key":"3261_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S1074-7613(03)00301-7","volume":"19","author":"S Maeda","year":"2003","unstructured":"Maeda, S. et al. IKK\u03b2 is required for prevention of apoptosis mediated by cell-bound but not by circulating TNF\u03b1. Immunity 19, 725\u2013737 (2003).","journal-title":"Immunity"},{"key":"3261_CR20","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1084\/jem.189.11.1839","volume":"189","author":"Z-W Li","year":"1999","unstructured":"Li, Z.-W. et al. The IKK\u03b2 subunit of I\u03baB kinase (IKK) is essential for nuclear factor \u03baB activation and prevention of apoptosis. J. Exp. Med. 189, 1839\u20131845 (1999).","journal-title":"J. Exp. Med."},{"key":"3261_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"A Howlett","year":"2002","unstructured":"Howlett, A. et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161\u2013202 (2002).","journal-title":"Pharmacol. Rev."},{"key":"3261_CR22","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s00125-018-4576-4","volume":"61","author":"I Gonz\u00e1lez-Mariscal","year":"2018","unstructured":"Gonz\u00e1lez-Mariscal, I. et al. Absence of cannabinoid 1 receptor in beta cells protects against high-fat\/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets. Diabetologia 61, 1470\u20131483 (2018).","journal-title":"Diabetologia"},{"key":"3261_CR23","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/sj.cdd.4401284","volume":"10","author":"M Maccarrone","year":"2003","unstructured":"Maccarrone, M. & Finazzi-Agro, A. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ. 10, 946 (2003).","journal-title":"Cell Death Differ."},{"key":"3261_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1677\/JME-08-0190","volume":"44","author":"G Turu","year":"2010","unstructured":"Turu, G. & Hunyady, L. Signal transduction of the CB1 cannabinoid receptor. J. Mol. Endocrinol. 44, 75\u201385 (2010).","journal-title":"J. Mol. Endocrinol."},{"key":"3261_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","volume":"12","author":"PJ Stork","year":"2002","unstructured":"Stork, P. J. & Schmitt, J. M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12, 258\u2013266 (2002).","journal-title":"Trends Cell Biol."},{"key":"3261_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1172\/JCI115836","volume":"90","author":"G Tiegs","year":"1992","unstructured":"Tiegs, G., Hentschel, J. & Wendel, A. AT cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196\u2013203 (1992).","journal-title":"J. Clin. Invest."},{"key":"3261_CR27","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0016-5085(98)70324-5","volume":"114","author":"C Trautwein","year":"1998","unstructured":"Trautwein, C. et al. Concanavalin A\u2014induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 114, 1035\u20131045 (1998).","journal-title":"Gastroenterology"},{"key":"3261_CR28","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1016\/j.bmcl.2012.08.004","volume":"22","author":"RJ Chorvat","year":"2012","unstructured":"Chorvat, R. J., Berbaum, J., Seriacki, K. & McElroy, J. F. JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities. Bioorg. Med. Chem. Lett. 22, 6173\u20136180 (2012).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"3261_CR29","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.molmet.2017.08.011","volume":"6","author":"T Jourdan","year":"2017","unstructured":"Jourdan, T. et al. Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice. Mol. Metab. 6, 1517\u20131528 (2017).","journal-title":"Mol. Metab."},{"key":"3261_CR30","doi-asserted-by":"publisher","first-page":"G357","DOI":"10.1152\/ajpgi.00456.2007","volume":"294","author":"SrV Siegmund","year":"2008","unstructured":"Siegmund, Sr. V. & Schwabe, R. F. Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G357\u2013G362 (2008).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"3261_CR31","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1124\/mol.64.6.1334","volume":"64","author":"I Lavon","year":"2003","unstructured":"Lavon, I. et al. A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation. Mol. Pharmacol. 64, 1334\u20131341 (2003).","journal-title":"Mol. Pharmacol."},{"key":"3261_CR32","doi-asserted-by":"crossref","unstructured":"Xu, X. et al. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet. Cytogenet. 171, 31\u201338 (2006).","DOI":"10.1016\/j.cancergencyto.2006.06.014"},{"key":"3261_CR33","doi-asserted-by":"crossref","unstructured":"B\u00e1tkai, S. et al. Endocannabinoids acting at vascular CB 1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat. Med. 7, 827\u2013832 (2001).","DOI":"10.1038\/89953"},{"key":"3261_CR34","doi-asserted-by":"crossref","unstructured":"Pertwee, R. G. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci. 76, 1307\u20131324 (2005).","DOI":"10.1016\/j.lfs.2004.10.025"},{"key":"3261_CR35","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/dom.13150","volume":"20","author":"T Jourdan","year":"2018","unstructured":"Jourdan, T. et al. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy. Diabetes Obes. Metab. 20, 698\u2013708 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"3261_CR36","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bbalip.2014.12.006","volume":"1851","author":"P Hawkins","year":"2015","unstructured":"Hawkins, P. & Stephens, L. PI3K signalling in inflammation. Biochim. Biophys. Acta 1851, 882\u2013897 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"3261_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1042\/bj3470369","volume":"347","author":"T G\u00f3mez del Pulgar","year":"2000","unstructured":"G\u00f3mez del Pulgar, T., Velasco, G. & Guzman, M. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B\/Akt. Biochem. J. 347, 369\u2013373 (2000).","journal-title":"Biochem. J."},{"key":"3261_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama, Y. & Brenner, D. A. Liver inflammation and fibrosis. J. Clin. Invest. 127, 55\u201364 (2017).","journal-title":"J. Clin. Invest."},{"key":"3261_CR39","doi-asserted-by":"crossref","unstructured":"Tan, S., Liu, H., Ke, B., Jiang, J. & Wu, B. The peripheral CB1 receptor antagonist JD5037 attenuates liver fibrosis via a CB1 receptor\/\u03b2-arrestin1\/Akt pathway. Br. J. Pharmacol. 177, 2830\u20132847 (2020).","DOI":"10.1111\/bph.15010"},{"key":"3261_CR40","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/cdd.2008.87","volume":"15","author":"J Zhang","year":"2008","unstructured":"Zhang, J. et al. Cyclic AMP inhibits JNK activation by CREB-mediated induction of c-FLIP L and MKP-1, thereby antagonizing UV-induced apoptosis. Cell Death Differ. 15, 1654 (2008).","journal-title":"Cell Death Differ."},{"key":"3261_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2015.12.015","volume":"423","author":"I Gonz\u00e1lez-Mariscal","year":"2016","unstructured":"Gonz\u00e1lez-Mariscal, I., Krzysik-Walker, S. M., Kim, W., Rouse, M. & Egan, J. M. Blockade of cannabinoid 1 receptor improves GLP-1R mediated insulin secretion in mice. Mol. Cell. Endocrinol. 423, 1\u201310 (2016).","journal-title":"Mol. Cell. Endocrinol."},{"key":"3261_CR42","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1111\/jcmm.13523","volume":"22","author":"H Shin","year":"2018","unstructured":"Shin, H. et al. Blockade of cannabinoid 1 receptor improves glucose responsiveness in pancreatic beta cells. J. Cell. Mol. Med. 22, 2337\u20132345 (2018).","journal-title":"J. Cell. Mol. Med."},{"key":"3261_CR43","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/nu10101347","volume":"10","author":"L Brissard","year":"2018","unstructured":"Brissard, L. et al. Orosensory detection of dietary fatty acids is altered in CB1R\u2212\/\u2212 mice. Nutrients 10, 1347 (2018).","journal-title":"Nutrients"},{"key":"3261_CR44","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1038\/onc.2017.38","volume":"36","author":"M Zhou","year":"2017","unstructured":"Zhou, M. et al. The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP\u2013PKA\u2013EGFR\u2013STAT3 axis. Oncogene 36, 4135\u20134149 (2017).","journal-title":"Oncogene"},{"key":"3261_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0023677215572841","volume":"49","author":"F Heymann","year":"2015","unstructured":"Heymann, F., Hamesch, K., Weiskirchen, R. & Tacke, F. The concanavalin A model of acute hepatitis in mice. Lab. Anim. 49, 12\u201320 (2015).","journal-title":"Lab. Anim."},{"key":"3261_CR46","doi-asserted-by":"publisher","first-page":"eaat4271","DOI":"10.1126\/scitranslmed.aat4271","volume":"10","author":"M Bodogai","year":"2018","unstructured":"Bodogai, M. et al. Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells. Sci. Transl. Med. 10, eaat4271 (2018).","journal-title":"Sci. Transl. Med."},{"key":"3261_CR47","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1096\/fj.201801145R","volume":"33","author":"I Gonz lez-Mariscal","year":"2019","unstructured":"Gonz lez-Mariscal, I. et al. Muscle cannabinoid 1 receptor regulates Il-6 and myostatin expression, governing physical performance and whole-body metabolism. FASEB J. 33, 5850\u20135863 (2019).","journal-title":"FASEB J."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03261-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03261-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03261-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:59:28Z","timestamp":1670255968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03261-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["3261"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03261-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"assertion":[{"value":"3 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1044"}}